相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Once-daily simeprevir (TMC435) with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1-infected patients in Japan: the DRAGON study
Norio Hayashi et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Once-Daily Simeprevir (TMC435) With Pegylated Interferon and Ribavirin in Treatment-Naive Genotype 1 Hepatitis C: The Randomized PILLAR Study
Michael W. Fried et al.
HEPATOLOGY (2013)
Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines
Kazuaki Chayama et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure
Stanislas Pol et al.
JOURNAL OF HEPATOLOGY (2013)
New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives
Christoph Welsch et al.
GUT (2012)
Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan
Hiromitsu Kumada et al.
JOURNAL OF HEPATOLOGY (2012)
Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C
N. Hayashi et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Response-guided and -unguided treatment of chronic hepatitis C
K. Rajender Reddy et al.
LIVER INTERNATIONAL (2012)
Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice
Christophe Hezode
LIVER INTERNATIONAL (2012)
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial
Michael Manns et al.
ANTIVIRAL THERAPY (2011)
Evolving epidemiology of hepatitis C virus
D. Lavanchy
CLINICAL MICROBIOLOGY AND INFECTION (2011)
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
JOURNAL OF HEPATOLOGY (2011)
Hepatitis C virus resistance to protease inhibitors
Philippe Halfon et al.
JOURNAL OF HEPATOLOGY (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
Kenneth E. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Retreatment of HCV Infection
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435
Oliver Lenz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Twelve Weeks Posttreatment Follow-up Is as Relevant as 24 Weeks to Determine the Sustained Virologic Response in Patients with Hepatitis C Virus Receiving Pegylated Interferon and Ribavirin
Michelle Martinot-Peignoux et al.
HEPATOLOGY (2010)
Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan
Hobyung Chung et al.
INTERVIROLOGY (2010)
Diagnostic and Treatment Algorithm of the Japanese Society of Hepatology: A Consensus-Based Practice Guideline
Namiki Izumi
ONCOLOGY (2010)
Re-treatment of Patients With Chronic Hepatitis C Who Do Not Respond to Peginterferon-α2b A Randomized Trial
Donald M. Jensen et al.
ANNALS OF INTERNAL MEDICINE (2009)
Epidemiology of hepatocellular carcinoma in Japan
Takeji Umemura et al.
JOURNAL OF GASTROENTEROLOGY (2009)
A randomized trial of pegylated interferon α-2b plus ribavirin in the retreatment of chronic hepatitis C
IM Jacobson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
分享论文
